logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025

También te puede interesar

Compartir
copy

Ganadores

Últimas noticias sobre criptomonedas

07:51

Japan's Interest Rate Hike Signal Triggers "Bloodletting" Worries in U.S. Markets, Fed's Rate Cut Prospect May Change

07:48

Lily Liu Criticizes The New York Times for Biased Reporting on Innovation and AI

07:31

BlackRock: Tokenization is evolving at a pace comparable to the early Internet, poised for significant growth

07:29

Whale "pension-usdt.eth" yesterday saw its ETH long position fall below the average price, with a position size reaching $56 million.

07:26

Dark Pool DEX HumidiFi to Launch ICO, Leading in Trading Volume Among Solana Ecosystem DEXs

Leer más
Comunitario
icon
icon
icon
icon
icon
icon
icon

Atención al cliente@weikecs

Cooperación empresarial@weikecs

Trading cuantitativo y MM[email protected]

Programa VIP[email protected]